Michele A. Anderson
Chief Development Officer
SEC EDGAR ↗Chief Development Officer at Braveheart Bio, Inc., filing insider transactions on 2026-08-07.
Total Purchases
$20K
1 transaction
Total Sales
—
0 transactions
Companies Traded
1
1 total filings
Active Since
2026-08-07
Last: 2026-08-07
Other Reporting Insiders at Braveheart Bio, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-08-07 | BRVE | Purchase | 1,111 | $18.00 | $20K | 332.2K | SEC ↗ |
Forbion Growth Opportunities Fund III Cooperatief U.A.
Michele A. Anderson (Braveheart Bio, Inc.) Insider Trades | Tormere